Clinical Significance of Measuring Prostate-Specific Antigen

被引：11
作者：
Arneth, Borros M. [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Inst Clin Chem & Lab Med, Mainz, Germany
来源：
LABMEDICINE | 2009年 / 40卷 / 08期
关键词：
DIGITAL RECTAL EXAMINATION; SERUM; CANCER; MEN; PERCENTAGE; RISK;
D O I：
10.1309/LMEGGGLZ2EDWRXUK
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The incidence of prostate-specific antigen (PSA) monitoring has increased in recent years. However, interpretation of the results is often ambiguous and leads to uncertainty for both the patient and the treating physician, Advantages and disadvantages of measuring PSA and possibilities for improved interpretation using the variable, PSA quotient are given.
引用
收藏
页码：487 / 491
页数：5
相关论文
共 50 条
  • [1] Is the era of prostate-specific antigen over?
    Djavan, Bob
    Rocco, Bernardo
    Stangelberger, Anton
    De Cobelli, Ottavio
    Marberger, Michael
    BJU INTERNATIONAL, 2007, 100 : 8 - 10
  • [2] Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection
    Yoneyama, Tohru
    Tobisawa, Yuki
    Kaneko, Tomonori
    Kaya, Takatoshi
    Hatakeyama, Shingo
    Mori, Kazuyuki
    Yoneyama, Mihoko Sutoh
    Okubo, Teppei
    Mitsuzuka, Koji
    Duivenvoorden, Wilhelmina
    Pinthus, Jehonathan H.
    Hashimoto, Yasuhiro
    Ito, Akihiro
    Koie, Takuya
    Suda, Yoshihiko
    Gardiner, Robert A.
    Ohyama, Chikara
    CANCER SCIENCE, 2019, 110 (08) : 2573 - 2589
  • [3] Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis
    Gorday, William
    Sadrzadeh, Hossein
    de Koning, Lawrence
    Naugler, Christopher T.
    CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1230 - 1234
  • [4] Prostate-specific antigen immunoassays on the BioCD
    Wang, Xuefeng
    Zhao, Ming
    Nolte, David D.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 393 (04) : 1151 - 1156
  • [5] PROSTATE-SPECIFIC ANTIGEN VELOCITY BEFORE AND AFTER ELIMINATION OF FACTORS THAT CAN CONFOUND THE PROSTATE-SPECIFIC ANTIGEN LEVEL
    Park, Jessica J.
    Chen, Ming-Hui
    Loffredo, Marian
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1217 - 1221
  • [6] ANALYTICAL PERFORMANCE GOALS FOR MEASURING PROSTATE-SPECIFIC ANTIGEN
    FRITSCHE, HA
    BABAIAN, RJ
    CLINICAL CHEMISTRY, 1993, 39 (07) : 1525 - 1529
  • [7] Regarding prostate-specific antigen: let's not shoot the messenger
    Goldstein, M. R.
    Mascitelli, L.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (02) : 207 - 210
  • [8] The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test
    McCormick, Mallory E.
    Haile, Zelalem T.
    JOURNAL OF CANCER EDUCATION, 2023, 38 (04) : 1313 - 1321
  • [9] Benign prostatic hyperplasia and prostate-specific antigen
    Pejcic, Tomislav
    Acimovic, Miodrag
    Dzamic, Zoran
    Radovanovic, Milan
    Hadzi-Djokic, Jovan
    VOJNOSANITETSKI PREGLED, 2015, 72 (05) : 447 - 453
  • [10] Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement
    Sundaresan, Vinaik M.
    Smani, Shayan
    Rajwa, Pawel
    Renzulli, Joseph
    Sprenkle, Preston C.
    Kim, Isaac Y.
    Leapman, Michael S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (01) : 41 - 48
12345